Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
BioImagene logo — company profile

BioImagene

Founded 2003 United States Sunnyvale, United States 37 employees Series D Total: $30.20M Biotechnology, Health Care

General Information

Company Name BioImagene
Founded Year 2003
Location United States Sunnyvale, United States
Employees 37
Industries Biotechnology, Health Care
Funding Stage Series D
Social

BounceWatch is an independent company data service, not affiliated with BioImagene. To contact BioImagene, visit bioimagene.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does BioImagene compare?

A PDF of BioImagene and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting BioImagene soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About BioImagene

BioImagene is a biotechnology and healthcare startup, founded in 2003 and headquartered in the United States. Acquired by Ventana Medical Systems in August 2010, it has since been a key player in delivering tissue-based diagnostic solutions for patients globally. The $26.00M Series D investment in August 19, 2008 involved prominent investors such as Artiman Ventures, Ascension Ventures, ICCP Venture Partners, Burrill & Company, and National Healthcare Services. Ventana's digital pathology, powered by BioImagene, offers comprehensive patient-focused solutions, enhancing workflow and efficiencies within pathology laboratories. This includes automated staining, image analysis, information management, and clinical lab optimization. With digital pathology solutions designed for academic medical centers, teaching hospitals, community hospitals, reference laboratories, and pharmaceutical and biotech companies, BioImagene plays a vital role in driving innovation in the healthcare industry.

Business keywords: Diagnosis Solutions, Tissue-based Diagnostic, Digital Pathology, Automated Staining, Patient Reports, Image Analysis, Information Management, Clinical Labs, Pathology Workflow, Efficiency Improvement, Medical Centers, Hospitals, Laboratories, Pharmaceutical Industry

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series D $26.00M 5
Artiman Ventures Ascension Ventures ICCP Venture Partners
Artiman Ventures, Ascension Ventures +3
19 Aug 2008
Series B $4.20M 3
ICCP Venture Partners Authosis Ventures
ICCP Venture Partners, Authosis Ventures +1
12 Oct 2004

BioImagene Alternatives & Competitors

View All Alternatives
BioImagene vs
PictorLabs Inc
PictorLabs Inc United States

The Virtual Staining Company

Series B
41 employees
AI, Biopharma
Compare BioImagene vs PictorLabs Inc
BioImagene vs
Deep Bio Inc.
Deep Bio Inc. Korea South

Al healthcare company with in-house expertise in deep learning and cancer pathology.

Series B
30 employees
AI, Biotechnology
Compare BioImagene vs Deep Bio Inc.
BioImagene vs
Kansas Laboratories Co.
Kansas Laboratories Co. Hong Kong S.a.r.

Every life counts.

Private Equity
5 employees
Biopharma, Biotechnology
Also compare with: BioImagene vs Clarapath Clarapath View all alternatives

FAQ About BioImagene

Ventana Medical Systems, Inc., a member of the Roche Group, is a world leader and innovator of tissue-based diagnostic solutions for patients worldwide. Ventana acquired BioImagene in August 2010. Through this acquisition, Ventana is uniquely positioned to deliver an end-to-end solution from aut...
BioImagene was founded in 2003.
BioImagene is headquartered in Sunnyvale, United States.
BioImagene operates in Biotechnology and Health Care. Its work centres on Diagnosis Solutions, Tissue-based Diagnostic, Digital Pathology and Automated Staining.
BioImagene has approximately 37 employees.
BioImagene has completed 2 funding rounds, raising a total of $30.20M. The latest funding stage is Series D.
Top alternatives and competitors to BioImagene include PictorLabs Inc, Deep Bio Inc., Kansas Laboratories Co., ASPYRA LLC, Virasoft Corporation. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
BioImagene and PictorLabs Inc are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for BioImagene, https://bouncewatch.com/company/bioimagene, updated 10 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes